Actor
Reminisciences SA
Exploits the crucial role of gut microbiota in human physiology and more specifically as we have discovered in Alzheimer’s disease.
CerebralX, a symbiotic treatment to restore altered gut microbiota and stop or delay Alzheimer’s disease, and ReminiTest, a diagnostic based upon microbiota profiling
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.09 Proteins & Peptides
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Endocrine & Metabolic, Neurology
Main sector
Biotech
Contact
Chemin de Closel 5
1020 Renens / VD